Abnormal Reverse Cholesterol Transport in Controlled Type II Diabetic Patients
- 1 December 1995
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (12) , 2130-2135
- https://doi.org/10.1161/01.atv.15.12.2130
Abstract
Abstract The high incidence and prevalence of coronary heart disease in diabetes mellitus is clearly established. The usual lipid pattern found in type II diabetic patients is a moderate increase in fasting triglyceride levels associated with low HDL cholesterol levels. These abnormalities are further amplified in the postprandial state. To study the effect of these alterations on reverse cholesterol transport, we isolated lipoprotein containing apoA-I but not apoA-II (LpA-I) particles by immunoaffinity chromatography from the plasma of well-controlled type II diabetic patients and nondiabetic matched control subjects. Different parameters involved in this antiatherogenic pathway were measured in both fasting and postprandial states. Diabetic patients had reduced levels of LpA-I particles that were protein enriched and phospholipid depleted. Gradient gel electrophoresis showed that control LpA-I particles had five distinct populations, whereas diabetic particles lacked the largest one. LpA-I isolated from diabetic plasma exhibited a decreased capacity to induce cholesterol efflux from Ob 1771 adipose cells both in fasting (15.1±10.0% versus 7.5±2.7%, P <.05) and postprandial (17.7±11.2% versus 7.7±3.9%, P <.05) states, whereas only control particles showed significantly higher ability to promote cholesterol efflux after the test meal ( P =.02). Lecithin:cholesterol acyltransferase activity measured with an exogenous substrate showed a 54% increase and an 18% decrease postprandially for control subjects and patients, respectively. Thus, the different abnormalities found in the fasting state were further amplified in the postprandial situation. This resulted in LpA-I particles with aberrant size and composition and decreased ability to accomplish their antiatherogenic role in type II diabetic patients.Keywords
This publication has 27 references indexed in Scilit:
- Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: Functional correlation with lecithin : cholesterol acyltransferaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 DiabetesDiabetic Medicine, 1991
- Placebo‐controlled Trial of the Effects of Guar Gum and Metformin on Fasting Blood Glucose and Serum Lipids in Obese, Type 2 Diabetic PatientsDiabetic Medicine, 1990
- Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and using anti-apolipoprotein A-I and A-II immunosorbent gelsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoproteinBiochemistry, 1988
- Apolipoprotein A-I containing lipoproteins in coronary artery diseaseAtherosclerosis, 1987
- High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.Journal of Clinical Investigation, 1987
- Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesBiochemical and Biophysical Research Communications, 1987
- Effects of postprandial lipemia on plasma cholesterol metabolism.Journal of Clinical Investigation, 1985
- Metformin Improves Peripheral Vascular Flow in Nonhyperlipidemic Patients with Arterial DiseaseJournal of Cardiovascular Pharmacology, 1984